Tuberculosis transmission in a renal dialysis center--Nevada, 2003.
Before diagnosis in August 2003, the HCW had experienced 6 weeks of cough, fatigue, and a 14-pound weight loss. Microscopic examination of sputum was 4+ positive for acid-fast bacilli (AFB), indicating infectiousness, and sputum culture yielded M. tuberculosis susceptible to all first-line anti-TB medications. The HCW was considered infectious for 3 months before TB diagnosis. During the 3-month period, employees and patients in the dialysis center were considered contacts and evaluated. Employee work schedules and patient dialysis schedules were reviewed to quantify the cumulative hours each person had been exposed to the HCW. In September 2003, initial screening of exposed persons included review of medical history, TB symptoms, and previous TST results. Persons without a previous positive TST result received a TST. All dialysis patients were referred for chest radiographs. Persons with TB symptoms of an abnormal chest radiograph submitted sputum for AFB testing and culture. Persons with a negative TST result (<5 mm induration) during initial testing were retested 12 weeks later. TB disease was defined as clinical signs or symptoms of TB with bacteriologic or radiographic confirmation. Latent TB infection (LTBI) was defined as a positive TST result ([greater than or equal to] 5 mm induration) and exclusion of TB disease by chest radiograph and sputum culture. Patients with a positive TST result who either had a previously documented negative TST result within the preceding 12 months or reported not having a previous positive TST were assumed to be recently infected by the HCW.
As of August 2004, a total of 481 contacts had been identified; 48 (10%) were patients from other jurisdictions who had been referred for evaluation by TB-control programs in their jurisdictions. Of the remaining 433 contacts, 95 (22%) were employees, and 291 (67%) were patients of the dialysis center; an additional 47 (11%) were other contacts *. Of the 433 contacts, 333 (77%) were evaluated (Table); 36 (11%) had a previous positive TST result. The remaining 297 contacts received a TST; 48 (16%) had a positive TST result. A total of 41 (12%) of the 333 evaluated contacts reported TB symptoms, but TB disease was excluded by chest radiograph and sputum culture.
The dialysis center employees were assumed to be immunocompetent and used as a surrogate group of contacts to evaluate for evidence of TB transmission. Of the 95 employees identified as contacts, 80 (84%) were evaluated; of these, 12 (15%) had a previously documented positive TST result. The remaining 68 employees received a TST; 13 (19%) had a positive TST result. Employees with positive TST results had chest radiographs that were normal. The 13 employees with a positive TST result were similar to the 55 employees with a negative TST result (i.e., by hours of exposure to the HCW, national origin, race/ethnicity, and age). Six (46%) of the 13 employees with a positive TST result had documented TST conversion (i.e., induration increase of [greater than or equal to] 10 mm compared with a routine TST obtained during the 2-year period before exposure); four worked on the same shift as the HCW.
No routine TB screening program had been conducted for patients at the dialysis center. One patient had a documented negative TST result before the exposure; 16 patients reported a previous positive TST result. Of the 291 patients identified as contacts, 212 (73%) were evaluated; 196 (92%) received a TST. A total of 76 (26%) had chest radiographs; five (7%) had abnormal radiographs, and TB disease was excluded subsequently by sputum culture. A total of 29 (15%) patients had a positive TST result. Patients with a positive TST result were older (median age: 65 years; range: 44-88 years) than those with a negative TST result (median age: 60 years; range: 11-95 years) (p = 0.01, Wilcoxon rank-sum). The median time of exposure to the HCW was the same (16 hours) for patients with positive and negative TST results. Of the 196 patients, 72 (37%) received direct care from the HCW; of these, nine (13%) had a positive TST result. Among the 72 patients, the median time of exposure was not different for those with a positive TST result compared with those with a negative TST result.
Employees with a positive TST result and exposed patients were offered a twice-weekly 9-month regimen of isoniazid. As of September 10, six employees and six patients had completed treatment for LTBI, and two patients had died of unrelated causes while receiving treatment. Two patients are continuing LTBI treatment. No secondary cases have been identified.
Reported by: L Hickstein, C McPherson, MD, D Kwalick, MD, V DeFriez. R Todd, DrPH, Nevada State Health Div. K Ijaz, MD, I Gonzalez, MD, M Haddad, MSN, P Tribble, MA, Div of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention; M Arduino, DrPH, Div of Healthcare Quality Promotion. National Center for Infectious Diseases; S Wei, Div of Applied Public Health Training, Epidemiology Program Office; J Miller, MD, EIS Officer, CDC.
Editorial Note: In this report, TST conversions among six immunocompetent employees suggest that M. tuberculosis transmission occurred within the renal dialysis center. Only one patient had a previously documented TST result for comparison; therefore, all 29 patients with a positive TST result were considered recently infected. Because exposure duration did not differ between the employees with positive TST results and those with negative TST results, no minimum level of exposure was associated with risk for infection with M. tuberculosis.
The findings in this report are subject to at least one limitation. The majority of persons with chronic renal failure have impaired delayed-type hypersensitivity, which might result in false-negative TST results (3-5). The positive TST results from this investigation likely underestimated the true prevalence of LTBI among these patients.
CDC recommends that after a known exposure to infectious TB disease, immunocompromised persons should receive treatment for presumptive LTBI, regardless of TST result (2). LTBI treatment was offered to all patients exposed to the HCW, even if their TST remained negative after repeat screening. However, convincing these high-risk contacts of the benefits of treating LTBI often was unsuccessful even after repeat counseling. Therefore, this investigation fell short of the national health objective for 2010 that 85% of TB contacts and other persons at high risk complete a course of treatment for LTBI (6). Because recently infected contacts are at high risk for having TB disease, the local health department is training the dialysis center employees to detect signs and symptoms of TB disease and ensure that anyone with TB symptoms is identified and treated promptly. If dialysis patients have TB disease diagnosed, maintenance dialysis in airborne isolation is required until they have completed enough anti-TB therapy to demonstrate clinical improvement and have negative M. tuberculosis sputum cultures.
TB infection has a higher risk for progression to TB disease among renal dialysis patients because of their older age and immunocompromised status associated with chronic renal failure and other illnesses (7). Studies in New Jersey and California have documented TB disease rates six to 11 times greater among hemodialysis patients than among the overall state populations (8,9). Because these patients spend more time in health-care settings, when M. tuberculosis infection progresses to TB disease, they can expose other persons who also are at greater risk for disease. Therefore, despite the limitations of TST in this population, early detection and treatment of LTBI is imperative (2). All dialysis patients should be tested at least once for a baseline TST result and rescreened if TB exposure is detected (2,10).
TABLE. Results of tuberculin skin tests (TSTs) of tuberculosis (TB) contacts at an outpatient renal dialysis center--Nevada, 2003 Employees Patients (n = 95) (n = 291) Category No. (%) No. (%) Total evaluated ([dagger]) 80 (84) 212 (73) Previous positive TST results ([section]) 12 (15) 16 (8) Total tested ([paragraph]) 68 (85) 196 (92) Positive TST result ** 13 (19) 29 (15) Positive TST result on initial test ([double dagger]) 7 (54) 21 (72) Positive TST result on repeat test ([subsection]) 6 (46) 8 (28) TST conversions ([paragraphs]) 6 (46) 1 (3) Other (*) Total (n = 47) (n = 433) Category No. (%) No. (%) Total evaluated ([dagger]) 41 (87) 333 (77) Previous positive TST results ([section]) 8 (20) 36 (11) Total tested ([paragraph]) 33 (80) 297 (89) Positive TST result ** 6 (18) 48 (16) Positive TST result on initial test ([double dagger]) 6 (100) 34 (71) Positive TST result on repeat test ([subsection]) 0 (0) 14 (29) TST conversions ([paragraphs]) 0 (0) 7 (15) (*) Other includes relatives of the health-care worker (HCW) with TB (n = two), persons who accompanied patients to the dialysis center (n = 38), and persons with unidentified relationships to the HCW (n = seven). ([dagger]) Persons who underwent review of medical history, TB symptoms, and previous TST results. ([section]) Persons evaluated who reported or had a previously documented positive TST result. ([paragraph]) Persons who received a TST during this contact investigation. (**) Persons with a TST result of [greater than or equal to] 5 mm induration. ([double dagger]) Persons who received a TST immediately after TB was diagnosed in the HCW. ([subsections]) TST was repeated 12 weeks later on all persons with a negative TST result (<5 mm induration) during the initial screening. ([paragraphs]) Documented induration increase of [greater than or equal to] 10 mm compared with a routine TST obtained during the 2-year period before the exposure among persons with a positive TST result.
(*) Relatives of the HCW, persons who accompanied patients to the dialysis center, and persons with unidentified relationships to the HCW.
(1.) Mitwalli A. Tuberculosis in patients on maintenance dialysis. Am J Kidney Dis 1991;18:579-82.
(2.) CDC. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000;49(No. RR-6).
(3.) Poduval R, Hammes MD. Tuberculosis screening in dialysis patients is the tuberculin test effective? Clin Nephrol 2003;59:436-40.
(4.) Smirnoff M, Patt C, Seckler B, Adler JJ. Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest 1998; 113:25-7.
(5.) Sester M, Sester U, Clauer P, et al. Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney Int 2004;65:1826-34.
(6.) U.S. Department of Health and Human Services. Healthy People 2010, 2nd ed. With Understanding and Improving Health and Objectives for Improving Health (2 vols.). Washington, DC: U.S. Department of Health and Human Services, 2000.
(7.) CDC. Screening for tuberculosis infection in high-risk populations: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR 1995;44(No. RR-11).
(8.) Simon TA, Paul S, Warrengerg D, Tokars JI. Tuberculosis in hemodialysis patients in New Jersey: a statewide study. Infect Control Hosp Epidemiol 1999;20:607-9.
(9.) Ahmed AT, Karter AJ. Tuberculosis in California dialysis patients. Int J Tuberc Lung Dis 2004;8:341-5.
(10.) Tokars J, Miller B. Tuberculin skin testing of ESRD patients. Am J Kidney Dis 1997;30:456-7.
|Printer friendly Cite/link Email Feedback|
|Author:||Santibanez, T.; Barker, L; Santoli, J.; Bridges, C.; Euler, G.; McCauley, M.|
|Publication:||Morbidity and Mortality Weekly Report|
|Date:||Sep 24, 2004|
|Previous Article:||Progress toward global eradication of dracunculiasis, 2002-2003.|
|Next Article:||West Nile virus activity--United States, September 15-21, 2004.|